Posted on November 09, 2011
Endocrinologic and Metabolic Drugs Advisory Committee
- FDA Main Presentations for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF – 7.33MB)4 (PDF - 1.8MB)
- Slides for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee5
- Merck Backup Presentations for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF – 94KB)6 (PDF - 94KB)
- Merck Main Presentations for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF – 1.12MB)7 (PDF - 1.1MB)
- FDA Backup Presentations for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF – 171KB)8 (PDF - 189KB)
- Final Meeting Roster for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee9 (PDF - 16KB)
- Final Questions for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee10 (PDF - 15KB)
- Final Agenda for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee11 (PDF - 12KB)
- 2011 Meeting Materials, Endocrinologic and Metabolic Drugs Advisory Committee12
National Mammography Quality Assurance Advisory Committee
- FDA Presentation13 (PDF - 159KB)
- ACR Presentation14 (PDF - 3.3MB)
No hay comentarios:
Publicar un comentario